OPHTHALMIC MEDICAL DEVICE

Brand Owner (click to sort) Address Description
ALPHAEUS SANTEN PHARMACEUTICAL CO., LTD. 4-20 Ofuka-cho, Kita-ku Osaka-shi Osaka 530-8552 Japan Ophthalmic medical device, namely, glaucoma tube shunt; surgical apparatus and instruments for use in ophthalmic surgery; medical device for non-laser glaucoma surgery; ocular implants and devices; ocular implants and devices for use in treating glaucoma; ocular implants and devices, namely, shunts, stents, ophthalmic cutting instruments, shunt and stent applicators, and vision screening instruments, for use in treating glaucoma;
DIVERTEX SANTEN PHARMACEUTICAL CO., LTD. 4-20 Ofuka-cho, Kita-ku Osaka-shi Osaka 530-8552 Japan Ophthalmic medical device, namely, glaucoma tube shunt; surgical apparatus and instruments for use in ophthalmic surgery; medical device for non-laser glaucoma surgery; ocular implants and devices; ocular implants and devices for use in treating glaucoma; ocular implants and devices, namely, shunts, stents, ophthalmic cutting instruments, shunt and stent applicators, and vision screening instruments, for use in treating glaucoma;
IONTIC BAUSCH + LOMB IRELAND LIMITED 3013 Citywest Business Campus Dublin 24 Ireland Ophthalmic medical device, namely, a drug delivery system;
REGAVIS SANTEN PHARMACEUTICAL CO., LTD. 4-20 Ofuka-cho, Kita-ku Osaka-shi Osaka 530-8552 Japan Ophthalmic medical device, namely, glaucoma tube shunt; surgical apparatus and instruments for use in ophthalmic surgery; medical device for non-laser glaucoma surgery; ocular implants and devices; ocular implants and devices for use in treating glaucoma; ocular implants and devices, namely, shunts, stents, ophthalmic cutting instruments, shunt and stent applicators, and vision screening instruments, for use in treating glaucoma;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. This invention relates to ophthalmic devices and methods for their production where the ophthalmic device contain a polymer and at least one heterocyclic compound comprising at least one N-Cl and/or N-Br bond.